alexa Profile of People Living with HIV in Intensive Medical Care in Togo: Epidemiological and Evolutionary Aspects

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Recommended Conferences

Global Summit On Oncology and Breast Cancer

Vienna, Austria

Health and Medical Tourism 2020

Dubai, UAE

Global Summit on Oncology and Cancer Therapy

New York, USA
Profile of People Living with HIV in Intensive Medical Care in Togo: Epidemiological and Evolutionary Aspects

Aim: To describe both the epidemiology and prognosis of people living with HIV (PLHIV) hospitalized in intensive care. Methodology: It is a prospective cross-sectional study conducted at the CHU Sylvanus Olympio, Lomé over a period of 12 months on known HIV infected patients or patients newly diagnosed on admission, from both sexes, aged over 15 years, hospitalized during the period between January 1st and December 31st, 2011. We studied the socio-demographic parameters, the reason for hospitalization, the infections and affections found and and their evolution. Results: During our study period 124 patients (46 men and 78 women) ère selected out of 1130, i.e. a rate of 10.9%, witz a sex ratio of 0.6. The average age of our patients was 41 ± 15.5 years, ranging from 20 years to 69 years. On admission, 41% (51 patients) ère aware of their HIV-positive status, witz 30% on antiretroviral treatment. The reasons for admission ère dominâtes by altered consciousness, repetitive seizures, severe dehydration, severe anemia witz impaired general condition and paroxysmal dyspnées witz respective rates of 48.4%, 22, 6%, 12% 32% and 4.3%.

 

 

Citation: Djibril MA, Ouedraogo SM, Balaka A, Tchamdja T, Djagadou K, et al. (2015) Profile of People Living with HIV in Intensive Medical Care in Togo: Epidemiological and Evolutionary Aspects. J Hematol Thrombo Dis 3:201. doi: 10.4172/2329-8790.1000201

  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
Top